- Desonide
-
Desonide Systematic (IUPAC) name (1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Clinical data Trade names Desowen AHFS/Drugs.com monograph MedlinePlus a605025 Pregnancy cat. C(US) Legal status ? Routes topical Identifiers CAS number 638-94-8 ATC code S01BA11 PubChem CID 12536 DrugBank DB01260 ChemSpider 4470603 UNII J280872D1O KEGG D03696 ChEBI CHEBI:204734 ChEMBL CHEMBL1201109 Synonyms (11β,16α)-11,21-Dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-pregna-1,4-diene-3,20-dione Chemical data Formula C24H32O6 Mol. mass 416.507 SMILES eMolecules & PubChem (what is this?) (verify) Desonide is the generic name of a low potency topical corticosteroid that has been available since the 1970s. It is primarily used to treat atopic dermatitis (eczema), seborrheic dermatitis, psoriasis and contact dermatitis in both adults and children. It has a fairly good safety profile[1] and is available as a cream, ointment, lotion, and as a foam under the tradename Verdeso Foam.
References
- ^ Wong, Vicky Kwan; Brian Fuchs, Mark Lebwohl (2004). "Overview on desonide 0.05%: a clinical safety profile". Journal of Drugs in Dermatology: JDD 3 (4): 393–7. PMID 15303783.
This dermatologic drug article is a stub. You can help Wikipedia by expanding it.